APAC Healthcare Weekly (Jan 19)- Samsung Biologics, Daiichi Sankyo, Eisai, Sun Pharma, Biocon
APAC healthcare companies got approvals for new products as well as clinical trials. The companies continued with acquisitions and collaborations...
621 Views
Company Coverage Temporary Coverage Changes
We make a number of temporary changes to our company coverage responsibilities with immediate effect due to Matt Montgomerie's period of...
117 Views
AFT Pharmaceuticals — Making progress on growth strategy
AFT Pharmaceuticals has provided an investor update for Q2 CY25 (Q1 FY26), summarising material progress made across its global expansion and...
261 Views
AFT Pharmaceuticals — Setting the stage for sustained long-term growth
AFT Pharmaceuticals reported FY25 revenues of N Z$208m, posting a strong recovery in H2, with dissipating headwinds and traditional H2 seasonality...
343 Views
AFT Pharmaceuticals FY25 Result—Edging Ahead
AFT Pharmaceuticals' core ANZ business continues to perform strongly, with Australia being the highlight and margin expansion observed.
235 Views